Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Precise Exercise Regimen for Cancer Care (PERCC): A Pilot Study [NA]
A pilot clinical trial evaluating a precise exercise regimen for cancer care in patients with non-small cell lung cancer; the study is not y…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors [Phase 1, Phase 2]
Phase 1/2 dose-finding study evaluating safety, pharmacokinetics, and dose optimization of a new therapy in advanced refractory solid tumors…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Clinical Study for the Efficacy and Safety of BL0020 Injection in Patients With Small Cell Lung Cancer Transformed From Non-Small Cell Lung Cancer Following EGFR TKI Therapy [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study of BL0020 injection for small cell lung cancer transformed from non-small cell lung c…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322) [Phase 1, Phase 2]
A Phase 1/2 trial evaluating tuvusertib in combination with cemiplimab for non-small cell lung cancer is currently active and not recruiting…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Efficacy of Anti-CTLA-4 Antibody Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-III Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 neoadjuvant trial is evaluating the combination of an anti-CTLA-4 antibody with Sintilimab and chemotherapy for resectable stage I…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: ctDNA Monitoring Guides the Treatment of NSCLC With Befotertinib Combined With Radiotherapy [Phase 2]
This clinical trial update describes a phase 2 study in which ctDNA monitoring guides the use of Befotertinib plus radiotherapy for advanced…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: First in Human Study of TORL-1-23 in Participants With Advanced Cancer [Phase 1]
TORL Biotherapeutics announced a first-in-human Phase 1 trial of TORL-1-23 for advanced cancers. The study is currently recruiting and inclu…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
This ClinicalTrials.gov entry describes a study by A2 Biotherapeutics evaluating HLA LOH analysis and apheresis for CAR-T cell manufacturing…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: All-Trans Retinoic Acid (ATRA) and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 clinical trial update evaluating the combination of All-Trans Retinoic Acid (ATRA) and atezolizumab for recurrent or metastatic no…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE) [Phase 2]
Clinical trial update for RP1 as a monotherapy and in combination with nivolumab (IGNYTE) in Phase 2 across several cancers; the study is cu…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: A Study Evaluating Furmonertinib Plus Platinum-based Doublet Chemotherapy Versus Osimertinib in Patients With Epidermal Growth Factor Receptor (EGFR) Sensitizing Mutation-Positive Non-squamous Non-Small Cell Lung Cancer (NSCLC) and Brain Metastases [Phase 3]
A Phase 3 trial evaluating furmonertinib plus platinum-based chemotherapy versus osimertinib in patients with EGFR-sensitizing mutation-posi…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation [Phase 1]
Phase 1 study to evaluate safety, pharmacokinetics, and activity of GDC-6036 alone or in combination in participants with KRAS G12C-mutant a…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study [Phase 2]
A Phase 2 trial (The Knight SHIFT Study) is comparing morning versus afternoon administration of immunotherapy for advanced or metastatic so…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Local Ablative Therapy to Oligoresidual Metastasis in EGFR Mutated Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating local ablative therapy for oligometastatic lesions in EGFR-mutated non-small cell lung cancer, currently r…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Firmonertinib Versus Platinum Based Chemotherapy as First-line Treatment for NSCLC With EGFR PACC or EGFR l861q Mutation [Phase 3]
A Phase 3 trial is evaluating firmonertinib versus platinum-based chemotherapy as first-line treatment for advanced non-small cell lung canc…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
This entry describes a Phase 2 clinical trial evaluating cemiplimab plus chemotherapy, comparing a standard combination with an augmented re…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Diclofenac for the Treatment of Patients With Metastatic Non-small Cell Lung Cancer on Single Agent Immunotherapy [Phase 2]
Phase 2 clinical trial evaluating diclofenac in patients with metastatic non-small cell lung cancer who are receiving single-agent immunothe…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Sarcopenia and Cachexia in Patients With Lung Cancer
This clinical trial update indicates an ongoing study examining sarcopenia and cachexia in patients with lung cancer (both non-small cell an…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)] [Phase 2]
A Phase 2 trial evaluating the LBL-024 combination in patients with advanced solid tumours, including a sub-study in non-small cell lung can…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node Involvement [Phase 2]
A Phase 2 clinical trial investigating neoadjuvant chemo-immunotherapy followed by surgical resection for locally advanced non-small cell lu…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Neoadjuvant Platform Trial in Non-Small Cell Lung Cancer [Phase 2]
Phase 2 neoadjuvant platform trial in non-small cell lung cancer sponsored by the Canadian Cancer Trials Group; the study is currently activ…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLC [Phase 2]
A Phase 2 clinical trial update evaluating Ivonescimab alone and in combination with carboplatin/pemetrexed for non-small cell lung cancer, …
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer [EARLY_Phase 1]
An early-phase 1 trial evaluating low-dose interleukin-2 in combination with pembrolizumab for stage IV non-small cell lung cancer is curren…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Preoperative Structured Exercise Programme on Patients With Non-Small Cell Lung Cancer [NA]
This document reports a clinical trial evaluating a preoperative structured exercise program for patients with Non-Small Cell Lung Cancer th…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AST2303 Tablets (ABK3376 Tablets) in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 study to evaluate safety, tolerability, pharmacokinetics, and preliminary efficacy of AST2303 (ABK3376) tablets in adults with loc…